GABAA receptor diversity and pharmacology

Cell and Tissue Research

Volumn 326, Issue 2, 2006, Pages 505-516

  Mohler H ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Anxiety; Benzodiazepines; Critical period plasticity; Gamma aminobutyric acid; Learning and memory

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA2; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA3; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA5; 5ALPHA PREGNANE 3,21 DIOL 20 ONE; 6 FLUORO 2,9 DIHYDRO 9 METHYL 2 PHENYL 4 (1 PYRROLIDINYLCARBONYL) 1H PYRIDO[3,4 B]INDOL 1 ONE; 7 TERT BUTYL 3 (2,5 DIFLUOROPHENYL) 6 (2 METHYL 2H 1,2,4 TRIAZOL 3 YLMETHOXY) 1,2,4 TRIAZOLO[4,3 B]PYRIDAZINE; ALCOHOL; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; DIAZEPAM; ELB 139; ENFLURANE; ETOMIDATE; FLUNITRAZEPAM; GABOXADOL; HALOTHANE; INDIPLON; ISOFLURANE; L 655708; NEUROSTEROID; OCINAPLON; PROPOFOL; TPA 023; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZALEPLON; ZOLPIDEM;

ANXIETY DISORDER; ASSOCIATIVE MEMORY; BEHAVIOR; BRAIN DEVELOPMENT; BRAIN DISEASE; CELL MATURATION; DRUG RECEPTOR BINDING; EXPERIENCE; HIPPOCAMPUS; HUMAN; INTERNEURON; LEARNING; MEMORY DISORDER; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; PHENOTYPE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; REVIEW; SCHIZOPHRENIA; SEDATION; SENSORIMOTOR FUNCTION; SLEEP DISORDER; SPATIAL MEMORY; SPIKE WAVE; TRANQUILIZING ACTIVITY; VISUAL CORTEX;

ANIMALS; ANXIETY DISORDERS; GAMMA-AMINOBUTYRIC ACID; HUMANS; INTERNEURONS; MEMORY; NEURAL INHIBITION; PYRAMIDAL CELLS; RECEPTORS, GABA-A; SCHIZOPHRENIA; SLEEP DISORDERS; SYNAPSES; SYNAPTIC TRANSMISSION; VISUAL CORTEX;

EID: 33748925413     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-006-0284-3     Document Type: Review

References (122)

1. A-receptor synapses in the mammalian CNS. Trends Neurosci 18:333-340
2. A receptors. Br J Pharmacol 144:357-366
3. A receptors, is a non-sedating anxiolytic in rodents and primates. J Pharm Exp Ther 316:410-422
4. Atack JR, Wafford K, Tye SJ, Cook S, Sohal B, Pike A, Sur C, Melillo D, Bristow L, Bromidge F, et al (2006b) The in vivo properties of pagoclone in rat are most likely mediated by 5′-hydroxy pagoclone. Neuropharmacology (in press)
5. A receptors: classification on the bases of subunit structure and receptor function. Pharmacol Rev 50:291-313
6. Belelli D, Lambert JJ (2005) Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci 6:565-575
7. A receptors rendered diazepam-insensitive by point-mutated α-subunits. FEBS Lett 431:400-404
8. Bianchi MT, McDonald RL (2003) Neurosteroids shift partial agonist activation of GABA(A) receptor channels from low- to high-efficacy gating patterns. J Neurosci 23:10934-10943
9. Bormann J (2000) The "ABC" of GABA receptors. Trends Pharmacol Sci 21:16-19
10. A receptors. J Physiol (Lond) 497:753-759
11. Brickley SG, Revilla V, Cull-Candy SG, Wisden W, Farrant M (2001) Adaptive regulation of neuronal excitability by a voltage independent potassium conductance. Nature 409:88-92
12. A receptors. Br J Pharmacol 136:965-974
13. A-receptor function in the adult brain: insights from the oxytocin neurone. Trends Neurosci 23:190-195
14. Campagna JA, Miller KW, Forman SA (2003) Mechanisms of actions of inhaled anesthetics. N Engl J Med 348:2110-2124
15. Caulfield MP, Brown DA (1992) Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br J Pharmacol 106:231-232
16. 5 receptor inverse agonist which enhances cognition. J Med Chem 46:2227-2240
17. A alpha5 receptors with cognition enhancing properties. J Med Chem 47:5829-5832
18. Chevaleyre V, Castillo PE (2003) Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38:461-472
19. Cirone J, Rosahl TW, Reynolds DS, Newman RJ, O'Meara GF, Hutson PH, Wafford KA (2004) Gamma-aminobutyric acid type A receptor beta 2 subunit mediates the hypothermic effect of etomidate in mice. Anesthesiology 100:1438-1445
20. Collins I, Moyes C, Davey WB, Rowley M, Bromidge FA, Quirk K, et al (2002) 3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional delectivity for alpha 2/alpha 3-subtypes of human GABA(A) receptor-ion channels. J Med Chem 45:1887-1900
21. A receptor. J Neurosci 22:5572-5580
22. A receptors. Proc Natl Acad Sci USA 99:8980-8985
23. A receptors different from zolpidem, zopiclone and benzodiazepines. Neurosci Res Comm 25:139-148
24. Dellini-Stula A, Berdah-Tordjman D (1996) Antipsychotic effects of bretazenil, a partial benzodiazepine agonist in acute schizophrenia - a study group report. J Psychiatr Res 30:239-250
25. A receptors in the inferior olivary nucleus. J Neurophysiol 85:1686-1696
26. Dias R, et al (2005) Evidence for a significant role of alpha3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines. J Neurosci 25:10682-10688
27. Engel AK, Fries P, Singer W (2001) Dynamic predictions: oscillations and synchrony in top-down processing. Nat Rev Neurosci 2:704-716
28. A receptors: limits, insights, future developments. J Neuroscience 4:933-943
29. Fagiolini M, Hensch T (2000) Inhibitory threshold for critical-period activation in primary visual cortex. Nature 404:183-186
30. A circuits for visual cortical plasticity. Science 303:1681-1683
31. Ferster D (2004) Blocking plasticity in the visual cortex. Science 303:1619-1621
32. Foeller E, Feldmann DE (2004) Synaptic basis for developmental plasticity in somatosensory cortex. Curr Opin Neurobiol 14:89-95
33. Foster AC, Pelleymounter MA, Cullen MJ, Lewis D, Joppa M, Chen TK, Bozigian HP, Gross RS, Gogas KR (2004) In vivo pharmacological characterization of indiplon, a novel pyrazolopyrimidine sedative-hypnotic. J Pharmacol Exp Ther 311:547-559
34. Freund TF, Buzsaki G (1996) Interneurons of the hippocampus. Hippocampus 6:345-470
35. Fritschy JM, Brünig I (2003) Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. Pharmacol Ther 98:299-323
36. A receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol 359:154-194
37. A receptor subtypes with special reference to memory function and neurological disorders. In: Hensch TK, Fagiolini M (eds) Excitatory inhibitory balance: synapses, circuits and systems plasticity. Kluwer Academic/Plenum, New York, pp 215-228
38. 3-subunits with serotonergic and GABAergic neurons. Neuroscience 54:881-892
39. Geiger JR, Lubke J, Roth A, Frotscher M, Jonas P (1997) Submilli-second AMPA receptor-mediated signalling at a principal neuron-interneuron synapse. Neuron 18:1009-1023
40. A receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms. CNS Drug Rev 9:3-20
41. Gupta A, Wang Y, Markam H (2000) Organizing principles for a diversity of GABAergic interneurons and synapses in the neocortex. Science 287:273-278
42. Haefeli W, Martin JR, Schoch P (1990) Novel anxiolytics that act as partial agonists at benzodiazepine receptors. Trends Pharmacol Sci 11:452-456
43. Harris KD, Henze DA, Hirase H, Leinekugel X, Dragoi G, Czurko A, Buzsaki G (2002) Spike train dynamics predicts theta-related phase precession in hippocampal pyramidal cells. Nature 417:738-741
44. A receptors modulate expression of prepulse inhibition. Mol Psychiatry 10:201-207
45. Hensch TK (2005) Critical period plasticity in local cortical circuits. Nature Rev Neurosci 6:877-888
46. Hensch TK, Stryker MP (2004) Columnar architecture sculped by GABA circuits in developing cat visual cortex. Science 303:1678-1681
47. Huckle R (2004) Gaboxadol Lundbeck/Merck. Curr Opin Investig Drugs 5:766-773
48. Huntsmann MM, Porcello DM, Homanics GE, DeLorey TM, Huguenard JR (1999) Reciprocal inhibitory connections and network synchrony in the mammalian thalamus. Science 283:541-543
49. A receptor desensitization kinetics and its role in synapse function in rat cortical neurons. J Pysiol (Lond) 522:3-17
50. 1 subunit expression and paired-pulse depression are distinct properties of neonatal inhibitory GABAergic synaptic connections in the mouse superior colliculus. Eur J Neurosci 13:2088-2098
51. Jurd R, Arras M, Lambert S, Drexler B, Siegwart R, Crestani F, Zaugg M, Vogt KE, Ledermann B, Antkowiak B, et al (2003) General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit. FASEB J 17:250-252
52. Kandler K (2004) Activity-dependent organization of inhibitory circuits: lessons from the auditory system. Curr Opin Neurobiol 14:96-104
53. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V, Piomelli D (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9:76-81
54. Katona I, Sperlagh B, Sik A, Käfalvi A, Vizi ES, Mackie K, Freund TF (1999) Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19:4544-4558
55. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF (2001) Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21:9506-9518
56. A receptors in the hippocampus. J Neurosci 22:2513-2521
57. Klausberger T, Magill PJ, Marton LF, Roberts JDB, Cobden PM, Buzsaki G, Somogyi P (2003) Brain state- and cell type-specific firing of hippocampal interneurons in vivo. Nature 421:844-848
58. Kopp C, Rudolph U, Tobler I (2004a) Sleep EEG changes after zolpidem in mice. Neuroreport 15:2299-2302
59. Kopp C, Rudolph U, Löw K, Tobler I (2004b) Modulation of rhythmic brain activity by diazepam: GABA(A) receptor subtype and state specificity. Proc Natl Acad Sci USA 101:3674-3679
60. Krasowski MD, Koltchine VV, Rick CE, Ye Q, Finn SE, Harrison NL (1998) Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane. Mol Pharmacol 53:530-538
61. Kreitzer AC, Regehr WG (2001a) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29:717-727
62. Kreitzer AC, Regehr WG (2001b) Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids. J Neurosci 21:RC174
63. Lambert S, Arras M, Vogt KE, Rudolph U (2005) Isoflurane-induced surgical tolerance mediated only in part by beta3-containing GABA(A) receptors. Eur J Pharmacol 516:23-27
64. A receptor function. Angew Chem Int Ed 111:2852-2864
65. A receptor. J Pharmacol Exp Ther 314:717-724
66. Lewis DA, Hashimoto T, Volk DW (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6:312-324
67. Liao M, Sonner JM, Jurd R, Rudolph U, Borghese CM, Harris RA, Laster MJ, Eger EI 2nd (2005) Beta3-containing gammaaminobutyric acidA receptors are not major targets for the amnesic and immobilizing actions of isoflurane. Anesth Analg 101:412-418
68. Lippa A, Czobor P, Stark J, Beer B, Kostakis E, Gravielle M, Bandyopadhyay S, Russek SJ, Gibbs TT, Farb DH, Skolnick P (2005) Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator. Proc Natl Acad Sci USA 102:7380-7385
69. Llano I, Leresche N, Marty A (1991) Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents. Neuron 6:565-574
70. Löw K, Crestani F, Keist R, Benke D, Brunig I, Benson JA, Fritschy JM, Rulicke T, Bluethmann H, Möhler H, Rudolph U (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290:131-134
71. Maejima T, Ohno-Shosaku T, Kano M (2001) Endogenous cannabinoid mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29:729-738
72. Markram H, Toledo-Rodriguez M, Wang Y, Gupta A, Silbergerb G, Wu C (2004) Interneurons of the neocortical inhibitory system. Nat Rev Neurosci 10:793-807
73. A receptor subtypes in the amygdala. Eur J Neurosci 20:1281-1289
74. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgansberger W, Di Marzo V, Lutz B (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418:530-534
75. + channels of fast-spiking interneurons and pyramidal neurons of rat hippocampus. J Neurosci 18:1811-1825
76. 1 subtype. Nat Neurosci 3:587-592
77. Metha MR, Lee AK, Wilson MA (2002) Role of experience and oscillations in transforming a rate code into a temporal code. Nature 417:741-746
78. Mihic SJ, Ye Q, Wick MJ, Koltchine VV, Krasowski MD, Finn SE, Mascia MP, Valenzuela CF, Hanson KK, Greenblatt EP, et al (1997) Sites of alcohol and volatile anaesthetic action on GABA (A) and glycine receptors. Nature 389:385-389
79. Mody I, Pearce RA (2004) Diversity of inhibitory neurotransmission through GABA(A) receptors. Trends Neurosci 27:569-575
80. Möhler H (2001) Functions of GABA receptors: pharmacology and pathophysiology. In: Möhler H (ed) Pharmacology of GABA and glycine neurotransmission. Springer, Berlin Heidelberg New York, pp 101-116
81. Möhler H (2002) Pathophysiological aspects of diversity in neuronal inhibition: a new benzodiazepine pharmacology. Dialogues Clin Neurosci 4:261-269
82. A receptors, In: Martin DL, Olsen RW (eds) GABA in the nervous system: the view at fifty years. Lippincott, Philadelphia, pp 97-112
83. Möhler H, Fritschy JM, Rudolph U (2002) A new benzodiazepine pharmacology. J Pharm Exptl Ther 300:2-8
84. A receptors. In: Holsboer F, Ströhle A (eds) Anxiety and anxiolytic drugs. Handbook of experimental pharmacology, vol 169. Springer, Berlin Heidelberg New York, pp 225-247
85. Monyer H, Markram H (2004) Interneuron Diversity series: Molecular and genetic tools to study GABAergic interneuron diversity and function. Trends Neurosci 27:90-97
86. Moss SJ, Smart TG (2001) Constructing inhibitory synapses. Nat Rev Neurosci 2:240-250
87. Navarro JF, Buron E, Martin-Lopez M (2002) Anxiogenic-like activity of L-655,708, a selective ligand for the benzodiazepine site of GABA(A) receptors which contain the alpha-5 subunit, in the elevated plus-maze test. Prog Neuropsychopharmacol Biol Psychiatry 26:1389-1392
88. 5 subunit in social encounters between male mice. Aggress Behav 30:319-325
89. A receptor is concentrated in both inhibitory and excitatory synapses on cerebellar granule cells. J Neurosci 16:103-114
90. Nusser Z, Sieghart W and Somogyi P (1998) Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J Neurosci 18:1693-1703
91. A receptors in hippocampal pyramidal cells of the rat. Eur J Neurosci 13:428-442
92. O'Keefe J, Nadel L (1978) The hippocampus as a cognitive map. Clarendon, Oxford, pp 477-543
93. O'Keefe J, Recce ML (1993) Phase relationship between hippocampal place units and the EEG theta rhythm. Hippocampus 3:317-330
94. Paulsen O, Moser EI (1998) A model of hippocampal memory encoding and retrieval: GABAergic control of synaptic plasticity. Trends Neurosci 21:273-278
95. Pawelzik H, Hughes DI, Thomson AM (2002) Physiological and morphological diversity of immunocytochemically defined parvalbumin- and cholecystokinin- positive interneurons in CA1 of the adult rat hippocampus. J Comp Neurol 443:346-367
96. A receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101:815-850
97. A responses in hippocampal pyramidal cells. J Neurosci 12:4122-4132
98. Pitler TA, Alger BE (1994) Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G protein involvement in a presynaptic mechanism. Neuron 13:1447-1455
99. A receptors subtypes in the cerebellum of mouse and rat. J Neurochem 87:1444-1455
100. Represa A, Ben-Ari Y (2005) Trophic actions of GABA on neuronal develpment. Trends Neurosci 28:278-283
101. Reynolds DS, Rosahl TW, Cirone J, O'Meara GF, Haythornthwaite A, Newman RJ, Myers J, Sur C, Howell O, Rutter AR, et al (2003) Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms. J Neurosci 23:8608-8617
102. A receptors for the development of tolerance to the sedative action of diazepam in mice. J Neurosci 24:6785-6790
103. Rudolph U, Antkowiak B (2004) Molecular and neuronal substrates for general anaesthetics. Nat Rev Neurosci 5:709-720
104. A receptor function and dissection of pharmacology of benzodiazepines and general anaesthetics by mouse genetics. Annu Rev Pharmacol Toxicol 44:475-498
105. A receptor subtype functions. Curr Opin Pharmacol 6:18-23
106. A receptor subtypes. Nature 401:796-800
107. A receptor subtypes. Curr Top Med Chem 2:795-816
108. Skaggs WE, McNaughton BL, Wilson MA, Barnes CA (1996) Theta phase precession in hippocampal neuronal populations and the compression of temporal sequences. Hippocampus 6:149-172
109. Sternfeld F, Carling RW, Jelley RA, Ladduwahetty T, Merchant KJ, Moore KW, Reeve AJ, Street LJ, O'Connor D, Sohal B, et al (2004) Selective, orally active gamma-amonobutyric acidA alpha5 receptor inverse agonists as cognition enhancers. J Med Chem 47:2176-2179
110. Storustovu S, Ebert B (2003) Gaboxadol: in vitro interaction studies with benzodiazepines and ethanol suggest functional selectivity. Eur J Pharmacol 467:49-56
111. A receptor subtype. Proc Natl Acad Sci USA 98:6464-6469
112. Traub RD, Draguhn A, Whittington MA, Baldeweg T, Bibbig A, Buhl EH, Schmitz D (2002) Axonal gap junctions between principal neurons: a novel source of network oscillations, and perhaps epileptogenesis. Rev Neurosci 13:1-30
113. 1 subunit deletion prevents developmental changes of inhibitory synaptic currents in cerebellar neurons. J Neurosci 21:3009-3016
114. Vincent P, Marty A (1993) Neighboring cerebellar Purkinje cell communicate via retrograde inhibition of common presynaptic interneurons. Neuron 11:885-893
115. Wallner M, Hanchar HJ, Olsen RW (2003) Ethanol enhances alpha4 beta3 delta and alpha6 beta3 delta gamma-aminobutyric acid type A receptors at low concentration known to affect humans. Proc Natl Acad Sci USA 100:15218-15223
116. A receptor gene family: new opportunities for drug development. Curr Opin Drug Discov Dev 6:648-655
117. A receptors based on subunit composition In: Martin DL, Olsen RW (eds) GABA in the nervous system: the view at fifty years. Lippincott, Philadelphia, pp 113-126
118. Wiesel TN, Hubel DH (1963) Single cell responses in striate cortex of kittens deprived of vision in one eye. J Neurophysiol 26:1003-1017
119. Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410:588-92 [erratum appears in Nature 2001 411:974]
120. 5 subunit mediate the trance effect in aversive and appetitive conditioning and extinction of conditioned fear. Eur J Neurosci 20:1928-1936
121. A receptors to a dopamine hyperfunction. Proc Natl Acad Sci USA 102:17154-17159
122. Zeller A, Arras M, Lazaris A, Jurd R, Rudolph U (2005) Distinct molecular targets for the central respiratory and cardiac actions of the general anesthetics etomidate and propofol. FASEB J 12:1677-1679